Cargando…
MRKAd5 HIV-1 Gag/Pol/Nef Vaccine-Induced T-Cell Responses Inadequately Predict Distance of Breakthrough HIV-1 Sequences to the Vaccine or Viral Load
BACKGROUND: The sieve analysis for the Step trial found evidence that breakthrough HIV-1 sequences for MRKAd5/HIV-1 Gag/Pol/Nef vaccine recipients were more divergent from the vaccine insert than placebo sequences in regions with predicted epitopes. We linked the viral sequence data with immune resp...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3428369/ https://www.ncbi.nlm.nih.gov/pubmed/22952672 http://dx.doi.org/10.1371/journal.pone.0043396 |
_version_ | 1782241696411549696 |
---|---|
author | Janes, Holly Frahm, Nicole DeCamp, Allan Rolland, Morgane Gabriel, Erin Wolfson, Julian Hertz, Tomer Kallas, Esper Goepfert, Paul Friedrich, David P. Corey, Lawrence Mullins, James I. McElrath, M. Juliana Gilbert, Peter |
author_facet | Janes, Holly Frahm, Nicole DeCamp, Allan Rolland, Morgane Gabriel, Erin Wolfson, Julian Hertz, Tomer Kallas, Esper Goepfert, Paul Friedrich, David P. Corey, Lawrence Mullins, James I. McElrath, M. Juliana Gilbert, Peter |
author_sort | Janes, Holly |
collection | PubMed |
description | BACKGROUND: The sieve analysis for the Step trial found evidence that breakthrough HIV-1 sequences for MRKAd5/HIV-1 Gag/Pol/Nef vaccine recipients were more divergent from the vaccine insert than placebo sequences in regions with predicted epitopes. We linked the viral sequence data with immune response and acute viral load data to explore mechanisms for and consequences of the observed sieve effect. METHODS: Ninety-one male participants (37 placebo and 54 vaccine recipients) were included; viral sequences were obtained at the time of HIV-1 diagnosis. T-cell responses were measured 4 weeks post-second vaccination and at the first or second week post-diagnosis. Acute viral load was obtained at RNA-positive and antibody-negative visits. FINDINGS: Vaccine recipients had a greater magnitude of post-infection CD8+ T cell response than placebo recipients (median 1.68% vs 1.18%; p = 0·04) and greater breadth of post-infection response (median 4.5 vs 2; p = 0·06). Viral sequences for vaccine recipients were marginally more divergent from the insert than placebo sequences in regions of Nef targeted by pre-infection immune responses (p = 0·04; Pol p = 0·13; Gag p = 0·89). Magnitude and breadth of pre-infection responses did not correlate with distance of the viral sequence to the insert (p>0·50). Acute log viral load trended lower in vaccine versus placebo recipients (estimated mean 4·7 vs 5·1) but the difference was not significant (p = 0·27). Neither was acute viral load associated with distance of the viral sequence to the insert (p>0·30). INTERPRETATION: Despite evidence of anamnestic responses, the sieve effect was not well explained by available measures of T-cell immunogenicity. Sequence divergence from the vaccine was not significantly associated with acute viral load. While point estimates suggested weak vaccine suppression of viral load, the result was not significant and more viral load data would be needed to detect suppression. |
format | Online Article Text |
id | pubmed-3428369 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-34283692012-09-05 MRKAd5 HIV-1 Gag/Pol/Nef Vaccine-Induced T-Cell Responses Inadequately Predict Distance of Breakthrough HIV-1 Sequences to the Vaccine or Viral Load Janes, Holly Frahm, Nicole DeCamp, Allan Rolland, Morgane Gabriel, Erin Wolfson, Julian Hertz, Tomer Kallas, Esper Goepfert, Paul Friedrich, David P. Corey, Lawrence Mullins, James I. McElrath, M. Juliana Gilbert, Peter PLoS One Research Article BACKGROUND: The sieve analysis for the Step trial found evidence that breakthrough HIV-1 sequences for MRKAd5/HIV-1 Gag/Pol/Nef vaccine recipients were more divergent from the vaccine insert than placebo sequences in regions with predicted epitopes. We linked the viral sequence data with immune response and acute viral load data to explore mechanisms for and consequences of the observed sieve effect. METHODS: Ninety-one male participants (37 placebo and 54 vaccine recipients) were included; viral sequences were obtained at the time of HIV-1 diagnosis. T-cell responses were measured 4 weeks post-second vaccination and at the first or second week post-diagnosis. Acute viral load was obtained at RNA-positive and antibody-negative visits. FINDINGS: Vaccine recipients had a greater magnitude of post-infection CD8+ T cell response than placebo recipients (median 1.68% vs 1.18%; p = 0·04) and greater breadth of post-infection response (median 4.5 vs 2; p = 0·06). Viral sequences for vaccine recipients were marginally more divergent from the insert than placebo sequences in regions of Nef targeted by pre-infection immune responses (p = 0·04; Pol p = 0·13; Gag p = 0·89). Magnitude and breadth of pre-infection responses did not correlate with distance of the viral sequence to the insert (p>0·50). Acute log viral load trended lower in vaccine versus placebo recipients (estimated mean 4·7 vs 5·1) but the difference was not significant (p = 0·27). Neither was acute viral load associated with distance of the viral sequence to the insert (p>0·30). INTERPRETATION: Despite evidence of anamnestic responses, the sieve effect was not well explained by available measures of T-cell immunogenicity. Sequence divergence from the vaccine was not significantly associated with acute viral load. While point estimates suggested weak vaccine suppression of viral load, the result was not significant and more viral load data would be needed to detect suppression. Public Library of Science 2012-08-27 /pmc/articles/PMC3428369/ /pubmed/22952672 http://dx.doi.org/10.1371/journal.pone.0043396 Text en https://creativecommons.org/publicdomain/zero/1.0/ This is an open-access article distributed under the terms of the Creative Commons Public Domain declaration, which stipulates that, once placed in the public domain, this work may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. |
spellingShingle | Research Article Janes, Holly Frahm, Nicole DeCamp, Allan Rolland, Morgane Gabriel, Erin Wolfson, Julian Hertz, Tomer Kallas, Esper Goepfert, Paul Friedrich, David P. Corey, Lawrence Mullins, James I. McElrath, M. Juliana Gilbert, Peter MRKAd5 HIV-1 Gag/Pol/Nef Vaccine-Induced T-Cell Responses Inadequately Predict Distance of Breakthrough HIV-1 Sequences to the Vaccine or Viral Load |
title | MRKAd5 HIV-1 Gag/Pol/Nef Vaccine-Induced T-Cell Responses Inadequately Predict Distance of Breakthrough HIV-1 Sequences to the Vaccine or Viral Load |
title_full | MRKAd5 HIV-1 Gag/Pol/Nef Vaccine-Induced T-Cell Responses Inadequately Predict Distance of Breakthrough HIV-1 Sequences to the Vaccine or Viral Load |
title_fullStr | MRKAd5 HIV-1 Gag/Pol/Nef Vaccine-Induced T-Cell Responses Inadequately Predict Distance of Breakthrough HIV-1 Sequences to the Vaccine or Viral Load |
title_full_unstemmed | MRKAd5 HIV-1 Gag/Pol/Nef Vaccine-Induced T-Cell Responses Inadequately Predict Distance of Breakthrough HIV-1 Sequences to the Vaccine or Viral Load |
title_short | MRKAd5 HIV-1 Gag/Pol/Nef Vaccine-Induced T-Cell Responses Inadequately Predict Distance of Breakthrough HIV-1 Sequences to the Vaccine or Viral Load |
title_sort | mrkad5 hiv-1 gag/pol/nef vaccine-induced t-cell responses inadequately predict distance of breakthrough hiv-1 sequences to the vaccine or viral load |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3428369/ https://www.ncbi.nlm.nih.gov/pubmed/22952672 http://dx.doi.org/10.1371/journal.pone.0043396 |
work_keys_str_mv | AT janesholly mrkad5hiv1gagpolnefvaccineinducedtcellresponsesinadequatelypredictdistanceofbreakthroughhiv1sequencestothevaccineorviralload AT frahmnicole mrkad5hiv1gagpolnefvaccineinducedtcellresponsesinadequatelypredictdistanceofbreakthroughhiv1sequencestothevaccineorviralload AT decampallan mrkad5hiv1gagpolnefvaccineinducedtcellresponsesinadequatelypredictdistanceofbreakthroughhiv1sequencestothevaccineorviralload AT rollandmorgane mrkad5hiv1gagpolnefvaccineinducedtcellresponsesinadequatelypredictdistanceofbreakthroughhiv1sequencestothevaccineorviralload AT gabrielerin mrkad5hiv1gagpolnefvaccineinducedtcellresponsesinadequatelypredictdistanceofbreakthroughhiv1sequencestothevaccineorviralload AT wolfsonjulian mrkad5hiv1gagpolnefvaccineinducedtcellresponsesinadequatelypredictdistanceofbreakthroughhiv1sequencestothevaccineorviralload AT hertztomer mrkad5hiv1gagpolnefvaccineinducedtcellresponsesinadequatelypredictdistanceofbreakthroughhiv1sequencestothevaccineorviralload AT kallasesper mrkad5hiv1gagpolnefvaccineinducedtcellresponsesinadequatelypredictdistanceofbreakthroughhiv1sequencestothevaccineorviralload AT goepfertpaul mrkad5hiv1gagpolnefvaccineinducedtcellresponsesinadequatelypredictdistanceofbreakthroughhiv1sequencestothevaccineorviralload AT friedrichdavidp mrkad5hiv1gagpolnefvaccineinducedtcellresponsesinadequatelypredictdistanceofbreakthroughhiv1sequencestothevaccineorviralload AT coreylawrence mrkad5hiv1gagpolnefvaccineinducedtcellresponsesinadequatelypredictdistanceofbreakthroughhiv1sequencestothevaccineorviralload AT mullinsjamesi mrkad5hiv1gagpolnefvaccineinducedtcellresponsesinadequatelypredictdistanceofbreakthroughhiv1sequencestothevaccineorviralload AT mcelrathmjuliana mrkad5hiv1gagpolnefvaccineinducedtcellresponsesinadequatelypredictdistanceofbreakthroughhiv1sequencestothevaccineorviralload AT gilbertpeter mrkad5hiv1gagpolnefvaccineinducedtcellresponsesinadequatelypredictdistanceofbreakthroughhiv1sequencestothevaccineorviralload |